Fineberg H V
Bull Cancer. 1980;67(4):395-404.
Decision trees are models of the temporal and logical flow of clinical problems. Their purpose is to help the physician choose a clinical management strategy that offers the greatest expected value for the patient. Decision trees help answer questions such as:"should a risky diagnostic test be performed?" "Given our present knowledge, which of several available treatments is best for this patient?" "What are the expected benefits, risks, and financial costs of pursuing different stages of patient care?" Decision trees do not create new information, but they can provide new insights based on existing information. The principles of analyzing a clinical situation from a decision analytic perspective and of constructing and using a decision tree are illustrated with three clinical examples: a patient with possible urinary tract infection, a young man with Hodgkin's disease, and patients with chronic progressive liver failure. We present a simplified quantitative analysis to determine whether the patient with Hodgkin's disease should undergo a staging laparotomy. The last example serves as a prelude to R. Fuhrer's discussion of the expected value of test information. Following R. Fuhrer's presentation, we discuss some of the objections and advantages to medical decision analysis. Despite its limitations we believe decision analysis can be a powerful aid to medical practitioners.
决策树是临床问题时间和逻辑流程的模型。其目的是帮助医生选择一种能为患者带来最大预期价值的临床管理策略。决策树有助于回答诸如以下问题:“是否应进行有风险的诊断测试?” “根据我们目前的知识,几种可用治疗方法中哪种对该患者最佳?” “进行患者护理不同阶段的预期益处、风险和财务成本是什么?” 决策树不会创造新信息,但它们可以基于现有信息提供新的见解。通过三个临床实例说明了从决策分析角度分析临床情况以及构建和使用决策树的原则:一名可能患有尿路感染的患者、一名患有霍奇金病的年轻男子以及患有慢性进行性肝衰竭的患者。我们进行了一项简化的定量分析,以确定患有霍奇金病的患者是否应接受分期剖腹术。最后一个例子是R. 富勒对测试信息预期价值讨论的前奏。在R. 富勒的演讲之后,我们讨论了对医学决策分析的一些反对意见和优点。尽管存在局限性,但我们认为决策分析对医学从业者可能是一种强大的辅助工具。